LONDON, England—The impact of pulmonary vein isolation (PVI)—the mainstay of catheter ablation for atrial fibrillation (AF)—should not be attributed to placebo effects, according to the SHAM-PVI trial ...
TCTMD reported in-depth on the TAILORED-AF trial, May 29, 2024, at the HRS 2024 meeting. The full manuscript was subsequently published in Nature Medicine on February 14, 2025. The published results ...
New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results